Skip to content

Comparison of Pesticide and Pharmaceutical Contaminants Levels in Placenta and Cord Blood Samples of Pregnant Women With Fetal Growth Retardation and Healthy Pregnant Women

Comparison of Pesticide and Pharmaceutical Contaminants Levels in Placenta and Cord Blood Samples of Pregnant Women With Fetal Growth Retardation and Healthy Pregnant Women

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05088148
Enrollment
40
Registered
2021-10-21
Start date
2022-03-29
Completion date
2023-03-26
Last updated
2022-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fetal Growth Retardation

Brief summary

Aim: In this study, pesticide and pharmaceutical contaminants levels in the placenta and cord blood of pregnant women with fetal growth retardation and healthy pregnant women will be compared in placenta and cord blood samples after delivery.

Detailed description

The study will be conducted with a total of 40 pregnant women, 20 of whom are in the control groups and those with FGR diagnoses. Cases in both groups will be matched in terms of demographic information. Demographic information (including socioeconomic status, educational level, region of residence), ultrasound and Doppler examination results, newborn weight at birth, APGAR score, gender, mode of delivery, whether there is a need for neonatal intensive care or not will be recorded.

Interventions

OTHER. Pesticide and Pharmaceutical analysis

Pesticide and Pharmaceutical analysis will be done with LC-MS/MS device.

Sponsors

Kutahya Health Sciences University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Between the ages of 18-40 years * Gestational age between 320/7 - 396/7 weeks * Singleton pregnancy * For the FGR group: estimated fetal weight \<10th percentile * For the control group: being healthy pregnant * Intact amniotic membrane

Exclusion criteria

* Multiple pregnancies * Cardiovascular disease * Chronic hypertension * Autoimmune disease * Intrahepatic cholestasis of pregnancy * Preeclampsia-eclampsia * Sepsis * Placenta accreta spectrum * Abnormalities of placenta * The chromosomal or congenital structural anomaly of the fetus * Smoking * BMI \>30 kg/m2

Design outcomes

Primary

MeasureTime frameDescription
Pesticide and Pharmaceutical analysis1 yearPesticide and pharmaceutical contaminants levels in pregnant women's placenta and cord blood will be measured in placenta and cord blood samples after delivery.

Secondary

MeasureTime frameDescription
Multi logistic regression analysis.1 monthIf there is a significant difference in other data, including the pesticide and pharmaceutical contaminants levels, in the FGR group, the effect of each factor on the development of FGR will be analyzed by multi logistic regression analysis.
ROC analysis1 monthIf the pesticide and pharmaceutical contaminants levels is found to be significantly higher in the FGR group, the cut-off value will be obtained by ROC analysis.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026